P3 Health Partners Inc

P3 Health Partners, Inc. is a population health care management company, which engages in the provision of professional support services to doctors and clinicians. The firm offers capital efficient care model, data and technology, physician leadership and community outreach tools to create enhanced patient outcomes and experiences. The company was founded by Sherif Abdou and Amir Bacchus on August 20, 2020 and is headquartered in Henderson, NV.

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

P3 Health Partners Inc reports robust Q4 performance and eyes profitability in 2024

P3 Health Partners Inc demonstrated strong financial performance and strategic initiatives during the Q4 2022 earnings call, positioning the company for future growth and profitability. While facing challenges in managing costs and optimizing margins, the company remains optimistic about its financial outlook and growth prospects. By leveraging opportunities in market expansion and operational enhancements, P3 Health Partners Inc aims to achieve positive cash flow in 2024.

P3 Health Partners Inc reports improved Q1 performance and growth outlook

P3 Health Partners Inc showed improved financial performance and operational metrics in Q1.
The company is on track towards profitability, with a focus on growth and healthcare transformation.
Challenges include managing EBITDA losses, COVID impact, and provider relationships.
Opportunities lie in further improving metrics, expanding in newer markets, and enhancing care management.

P3 Health Partners Inc reports strong Q2 earnings and growth opportunities

P3 Health Partners Inc (PIII) demonstrated positive financial performance in Q2 2023, with strong revenue growth and improved margins.
The company's focus on operational efficiency, quality improvements, and growth objectives positions it well for future success.
While facing challenges in managing expenses and achieving profitability, P3 Health Partners Inc (PIII) has opportunities for growth and market expansion.
Overall, the company's sustained demand, efficient operations, and progress towards profitability indicate a promising outlook for stakeholders.

P3 Health Partners Inc reports solid Q3 results, eyes growth

P3 Health Partners Inc delivered a strong performance in Q3, focusing on revenue growth, cost management, and profitability.
While facing challenges such as timing issues and payer negotiations, the company remains optimistic about its future prospects.
Opportunities for growth include expanding partnerships, optimizing operational efficiency, and providing clearer financial guidance to stakeholders.
Overall, PIII's strategic initiatives position it well for continued success, with a positive outlook for 2024 and beyond.

P3 Health Partners reports strong 2023 growth and positive 2024 outlook

P3 Health Partners Inc delivered robust financial performance in 2023.
Strategic initiatives led to improved margins and revenue growth.
Challenges include managing expenses and potential regulatory changes.
Opportunities lie in partnerships, persistency rates, and revenue expansion.

P3 Health Partners reports strong Q1 earnings, eyes AI growth

P3 Health Partners Inc's Q1 2024 showed strong revenue growth and operational efficiencies.
The company is confident in achieving its EBITDA guidance through strategic partnerships and focus on high-risk populations.
Challenges include managing cash flow, capital requirements for growth, and effective high-risk population management.
Opportunities lie in AI partnerships, data analytics tools, and deeper provider engagement for better care outcomes.

P3 Health Partners reports robust Q2 results and eyes growth

P3 Health Partners showed strong performance in Q2 with revenue growth, cost reduction, and improved EBITDA loss. The company's focus on expense management and balance sheet strength position it well for future growth. Challenges remain in managing medical costs and achieving profitability, but opportunities for expansion and improved financial performance are evident.

P3 Health Partners reports Q3 loss, plans improvements for 2025

P3 Health Partners Inc faced challenges in Q3 2024 with a $71 million adjusted EBITDA loss, driven by retroactive adjustments and high medical utilization. Despite this, the company plans significant improvements in contracts, efficiency, and data analytics for 2025. Opportunities exist in optimizing working capital, strategic financing, and focusing on high-performance markets.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for third-quarter 2023 and file its Quarterly Report on Form 10-Q on Wednesday, November 8, 2023. In connection with this release, management will host a conference call and webcast to provide a corporate and financial update: Title & Webcast P3 Health Thi.

P3 Health Partners Schedules Third-Quarter 2023 Earnings Release and Conference Call

Augmedix

Talkspace

Zacks Medical Info Systems industry stocks like P3 Health Partners (PIII), Talkspace (TALK) and Augmedix (AUGX) are expected to gain from the new normal trends.

3 Medical Info Systems Stocks to Buy as Industry Trends Improve

Globalstar

Senseonics Holdings

The allure of penny stocks is undeniable. Their low price point, combined with the potential for high returns, makes them a tantalizing option for investors.

3 Top Penny Stocks To Buy Now According To Insiders

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that it will participate in the Lake Street Best Ideas Growth Conference in New York, New York on Thursday, September 14th, 2023. About P3 Health Partners (NASDAQ: PIII): P3 Health Partners Inc. is a leading population health management company committed to transforming healthcare by improving the lives of both pat.

P3 Health Partners to Participate in the Lake Street Best Ideas Growth Conference

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that it will participate at the upcoming Wells Fargo Healthcare Conference in Boston, Massachusetts. Management will give a presentation on Thursday, September 7th, 2023, at 4:30 PM Eastern Time. A webcast of the live event will be available on the P3 Investor Relations website at ir.p3hp.org. A replay will be avai.

P3 Health Partners to Present at Wells Fargo Healthcare Conference

P3 Health Partners Inc. (PIII) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Here's Why P3 Health Partners Inc. (PIII) is Poised for a Turnaround After Losing -28.57% in 4 Weeks

P3 Health Partners Inc. (NASDAQ:PIII ) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ET Company Participants Karen Blomquist - Vice President, Investor Relations Sherif Abdou - Chief Executive Officer & Co-Founder Bill Bettermann - Chief Operating Officer Atul Kavthekar - Chief Financial Officer Amir Bacchus - Chief Medical Officer Conference Call Participants Joshua Raskin - Nephron Research Ryan Daniels - William Blair Gary Taylor - TD Cowen Brooks O'Neil - Lake Street Capital Markets Operator Hello, and welcome to the P3 Health Partners Q2 2023 Earnings Call. [Operator Instructions] Please note, today's event is being recorded.

P3 Health Partners Inc. (PIII) Q2 2023 Earnings Call Transcript

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2023. “The results for the second quarter of 2023 show the power and trajectory of the P3 model. I'm delighted to say we had solid improvement across all key metrics. The strength we have seen in 2023 has given us the stability and momentum to drive.

P3 Health Partners Announces Second-Quarter 2023 Results

NEW YORK , Aug. 1, 2023 /PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of P3 Health Partners Inc. (NASDAQ: PIII). If you are a shareholder of P3 Health Partners Inc. and are interested in obtaining additional information regarding this investigation, free of charge, please visit us at: https://pjlfirm.com/p3-health-partners-inc/ You may also contact Robert H.

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating P3 Health Partners Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for second-quarter 2023 and file its quarterly report on Form 10-Q on Monday, August 7, 2023. In connection with this release, management will host a conference call and webcast to provide a corporate and financial update: Title & Webcast P3 Health Second-.

P3 Health Partners Schedules Second-Quarter 2023 Earnings Release and Conference Call

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces William “Bill” Bettermann as its Executive Vice President and Chief Operating Officer. Bill brings nearly 25 years of healthcare management experience to P3 with a strong track record of success in the value-based care arena. Previously Bill served in leadership roles at Optum Care, where he recently led the Pacifi.

P3 Health Partners Names William Bettermann as Chief Operating Officer

Big losses have plagued P3 Health Partners in the fast-growing sector of population health management and have resulted in severely depressed share prices. On the positive side, P3 losses continue to improve and share prices are climbing again. P3 CEO announced that recent $90 million funding and cost-cutting measures will help reach Adjusted EBITDA profitability in 2024.

P3 Health Partners On Solid Path To Profitability

P3 Health Partners is predicting gains in the number of Medicare Advantage patients as well as revenue this year. It saw double-digit gains in revenue in the first quarter.

Why Shares of P3 Health Partners Soared This Week

Akebia Therapeutics

Altus Power

Taboola

In the world of investment, penny stocks hold a unique position. Often priced at $5 per share or less, these are typically shares of small-cap companies that trade at relatively low prices.

4 Hot Penny Stocks To Watch This Week

One of the best-performing stocks this month is a company you might have never heard of. Shares of P3 Health Partners NASDAQ: PIII are up 182% so far in May, but a recent trendline break and volume decrease could signal a character shift.

After Soaring 182% Is Time To Ring The Register In P3 Health?

P3 Health Partners saw revenue rise and net losses fall in the first quarter. The company upgraded adjusted EBITDA predictions for 2023.

Why P3 Healthcare Shares Jumped Wednesday

P3 Health Partners Inc. (NASDAQ:PIII ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Karen Blomquist - Vice President, Investor Relations Sherif Abdou - Chief Executive Officer & Co-Founder Atul Kavthekar - Chief Financial Officer Amir Bacchus - Chief Medical Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Ryan Daniels - William Blair Josh Raskin - Nephron Research Gary Taylor - Cowen Operator Good afternoon, everyone, and welcome to the P3 Health Partners First Quarter Results Conference Call. Currently, all participants are in a listen-only mode.

P3 Health Partners Inc. (PIII) Q1 2023 Earnings Call Transcript

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the first quarter ended March 31, 2023. “We are off to a strong start in 2023. We achieved a medical margin of $39.2 million or 13.1% as a percentage of capitated revenue for the quarter, a key metric for validating the effectiveness of P3's model. As a result of the first quarter st.

P3 Health Partners Announces First-Quarter 2023 Results

Knnate Biopharma

Mangoceuticals Inc

Terawulf

Insiders think these are penny stocks to buy based on recent filings but are they worth the risk? The post 4 Penny Stocks To Buy According To Insiders This Quarter appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Penny Stocks To Buy According To Insiders This Quarter

P3 Health Partners Inc. (PIII) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Here Is Why Bargain Hunters Would Love Fast-paced Mover P3 Health Partners Inc. (PIII)

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for first-quarter 2023 and file its quarterly report on Form 10-Q on Wednesday, May 10, 2023. In connection with this release, management will host a conference call and webcast to provide a corporate and financial update: Title & Webcast P3 Health First-Q.

P3 Health Partners Schedules First-Quarter 2023 Earnings Release and Conference Call

P3 Health Partners Inc. (NASDAQ:PIII ) Q4 2022 Earnings Conference Call March 31, 2023 8:30 AM ET Company Participants Karen Blomquist - Director, IR Sherif Abdou - CEO Atul Kavthekar - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Joshua Raskin - Nephron Research Operator Good day, and welcome to the P3 Health Partners Fourth Quarter 2022 Earnings Conference Call. All participants will be in listen-only mode.

P3 Health Partners Inc. (PIII) Q4 2022 Earnings Call Transcript

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2022. “Results for 2022 are a testament to the strength of the P3 team and its commitment to improving clinical outcomes,” said Dr. Sherif Abdou, CEO of P3 Health Partners.

P3 Health Partners Announces Fourth Quarter and Full-Year 2022 Results

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (Nasdaq: PIII), a patient-centered and physician-led population health management company (the “Company”), today announced that it has entered into definitive agreements to sell securities in a private placement with a group of institutional investors. The lead institutional investors in the private placement are affiliates of Chicago Pacific Founders (“CPF”) and Leavitt Partners.

P3 Health Partners Inc. Announces Approximately $90 Million Private Placement

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announced that it will now release results for fourth-quarter 2022 and full-year ended December 31, 2022 on Friday, March 31, 2023 before the market open.

News for P3 Health Partners Inc Stock (PIII)